Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This pilot study will investigate the potential efficacy of VM100, a nutritional supplement specifically formulated for patients with DMD, on quality of life and physical symptoms. Twenty patients (aged 8 an over) will be enrolled to undergo a 10-week placebo-controlled intervention with VM100. Outcomes will include validated questionnaires and qualitative interview to assess impact on mental, cognitive and mood related measures, as well as endurance and fatigue).
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 6
Healthy Volunteers: f
View:
• Diagnosis of DMD confirmed by genetic report
• Age 8 years or older.
• Stable glucocorticoid and/or other medication regimen for at least 3 months before enrollment and throughout study participation.
Locations
United States
Florida
University of Florida
RECRUITING
Gainesville
Contact Information
Primary
Tanja Taivassalo
ttaivassalo@ufl.edu
(352) 294 - 8748
Time Frame
Start Date: 2026-07-27
Estimated Completion Date: 2028-12
Participants
Target number of participants: 20
Treatments
Experimental: VM100 Nutritional Supplement
Participants will receive the VM100 nutritional supplement orally twice daily for 10 weeks, consisting of 6 weeks of supplementation, followed by a 2-week washout period without supplementation, and a final 2 weeks of supplementation.
Related Therapeutic Areas
Sponsors
Leads: University of Florida